Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA PCBP1-AS1-mediated AR/AR-V7 deubiquitination enhances prostate cancer enzalutamide resistance
Boya Zhang, Mingpeng Zhang, Chunyi Shen, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 37

Showing 26-50 of 37 citing articles:

Enzalutamide-resistant related lncRNA NONHSAT210528 promotes the proliferation and invasion of prostate cancer
Chen Ye, Yuangui Chen, Shengfei Qin, et al.
Translational Andrology and Urology (2022) Vol. 11, Iss. 5, pp. 643-658
Open Access | Times Cited: 6
Nuclear transport maintenance of USP22-AR by Importin-7 promotes breast cancer progression
Gengxi Cai, Weiyao Kong, Yuan Liu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Association of LncRNA PCBP1-AS1 with cancer occurrence and development: A review
Yanping Wu, Jie Mou, Yuling Liu, et al.
Medicine (2023) Vol. 102, Iss. 43, pp. e35631-e35631
Open Access | Times Cited: 3
A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
Li Wang, Shao-Quan Zhou, Yu Zhou, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 5
The crosstalk between ubiquitination and endocrine therapy
Yidong Ge, Ziqing Zhan, Meng Ye, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 5, pp. 461-486
Closed Access | Times Cited: 2
Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review)
Monica Cantile, Margherita Cerrone, Maurizio Di Bonito, et al.
International Journal of Oncology (2023) Vol. 64, Iss. 1
Open Access | Times Cited: 2
The Role of Long Non-Coding RNAs in Epithelial-Mesenchymal Transition-Related Signaling Pathways in Prostate Cancer
Dexin Shen, Hongwei Peng, Caixia Xia, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 4
LINC01518 predicts poor prognosis of prostate cancer and promotes its progression by regulating hsa-miR-320a/CNKSR2 axis
Guodong Chen, Zixin Chen
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Long noncoding RNA mediates enzalutamide resistance and transformation in neuroendocrine prostate cancer
Zhe Zhu, Wenjing Xuan, Chaohui Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
The Roles of Ferroptosis-related Long Non-coding RNAs in Urologic Cancers
Wenchao Xie, Jie Gu, Zhenqian Qin, et al.
annals of urologic oncology (2023)
Open Access
Retraction Note: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC
Boya Zhang, Mingpeng Zhang, Yanjie Yang, et al.
Oncogene (2023) Vol. 42, Iss. 36, pp. 2711-2711
Open Access
Long Non-coding RNA INE1 Induced Autophagy Promotes Sensitivity of Prostate Cancer Cells to Cisplatin
Hezhen Chu, Kongdong Li, Jie Gu, et al.
annals of urologic oncology (2022), pp. 1-12
Open Access
Previous Page - Page 2

Scroll to top